Regulator of G-Protein Signaling 4 (RGS4) Controls Morphine Reward by Glutamate Receptor Activation in the Nucleus Accumbens of Mouse Brain |
Kim, Juhwan
(Department of Veterinary Anatomy, College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University)
Lee, Sueun (Department of Veterinary Anatomy, College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University) Kang, Sohi (Department of Veterinary Anatomy, College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University) Jeon, Tae-Il (Department of Animal Science, College of Agriculture and Life Science, Chonnam National University) Kang, Man-Jong (Department of Animal Science, College of Agriculture and Life Science, Chonnam National University) Lee, Tae-Hoon (Department of Oral Biochemistry, Dental Science Research Institute, School of Dentistry, Chonnam National University) Kim, Yong Sik (Department of Pharmacology, Seoul National University College of Medicine) Kim, Key-Sun (Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST)) Im, Heh-In (Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST)) Moon, Changjong (Department of Veterinary Anatomy, College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University) |
1 | Shen, J., Benedict Gomes, A., Gallagher, A., Stafford, K., and Yoburn, B.C. (2000). Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice. Synapse 38, 322-327. DOI |
2 | Snyder, G. L., Allen, P.B., Fienberg, A.A., Valle, C.G., Huganir, R.L., Nairn, A.C., Greengard, P. (2000). Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20, 4480-4488. DOI |
3 | Taymans, J. M., Leysen, J. E., and Langlois, X. (2003). Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions. J. Neurochem. 84, 1118-1127. DOI |
4 | Terzi, D., Gaspari, S., Manouras, L., Descalzi, G., Mitsi, V., and Zachariou, V. (2014). RGS9-2 modulates sensory and mood related symptoms of neuropathic pain. Neurobiol. Learn. Mem. 115, 43-48. DOI |
5 | Trujillo, K.A., and Akil, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87. DOI |
6 | Valverde, O., Mantamadiotis, T., Torrecilla, M., Ugedo, L., Pineda, J., Bleckmann, S., Gass, P., Kretz, O., Mitchell, J.M., Schutz, G., et al. (2004). Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology 29, 1122-1133. DOI |
7 | Jaw, S. P., Makimura, M., Oh, K.W., Hoskins, B., and Ho, I.K. (1994). Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol. Eur. J. Pharmacol. 257, 153-160. DOI |
8 | Kim, J., Ham, S., Hong, H., Moon, C., Im, H.I. (2016). Brain reward circuits in morphine addiction. Mol. Cells 39, 645-653. DOI |
9 | Jedynak, J., Hearing, M., Ingebretson, A., Ebner, S.R., Kelly, M., Fischer, R.A., Kourrich, S., and Thomas, M.J. (2016). Cocaine and amphetamine induce overlapping but distinct patterns of AMPAR plasticity in nucleus accumbens medium spiny neurons. Neuropsychopharmacology 41, 464-476. DOI |
10 | Kim, J., Yang, M., Son, Y., Jang, H., Kim, D., Kim, J.C., Kim, S.H., Kang, M.J., Im, H.I., Shin, T., et al. (2014). Glial activation with concurrent up-regulation of inflammatory mediators in trimethyltininduced neurotoxicity in mice. Acta Histochem. 116, 1490-1500. DOI |
11 | Lerea, L.S., and McNamara, J.O. (1993). Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calciumrequiring intracellular signaling pathways. Neuron 10, 31-41. DOI |
12 | Levitt, P., Ebert, P., Mirnics, K., Nimgaonkar, V.L., and Lewis, D.A. (2006). Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol. Psychiatry 60, 534-537. DOI |
13 | Liang, J., Li, Y., Ping, X., Yu, P., Zuo, Y., Wu, L., Han, J.S., and Cui, C. (2006). The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats. Peptides 27, 3307-3314. DOI |
14 | Liu, Z., Zhang, J.J. Liu, X.D., and Yu, L.C. (2012). Inhibition of CaMKII activity in the nucleus accumbens shell blocks the reinstatement of morphine-seeking behavior in rats. Neurosci. Lett. 518, 167-171. DOI |
15 | Manzoni, O.J. and Williams, J.T. (1999). Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 19, 6629-6636. DOI |
16 | Bishop, G., Cullinan, W., Curran, E., and Gutstein, H. (2002). Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis. 10, 334-343. DOI |
17 | Boehm, J., Kang, M.G., Johnson, R.C., Esteban, J., Huganir R.L., and Malinow, R. (2006). Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron 51, 213-225. DOI |
18 | Chartoff, E.H., and Connery H.S. (2014). It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Front. Pharmacol. 5, 116. |
19 | Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2- method. Methods 25, 402-408. DOI |
20 | Lomazzi, M., Slesinger, P.A., and Luscher, C. (2008). Addictive drugs modulate GIRK-channel signaling by regulating RGS proteins. Trends Pharmacol. Sci. 29, 544-549. DOI |
21 | Martin, G., Ahmed, S.H. Blank, T., Spiess, J., Koob, G.F., and Siggins, G.R. (1999). Chronic morphine treatment alters NMDA receptormediated synaptic transmission in the nucleus accumbens. J. Neurosci. 19, 9081-9089. DOI |
22 | Moron, J.A., Gullapalli, S., Taylor, C., Gupta, A., Gomes, I., Devi, L.A. (2010). Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 35, 955-966. DOI |
23 | Murray, F., Harrison, N.J., Grimwood, S., Bristow, L.J., and Hutson, P.H. (2007). Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats. Eur. J. Pharmacol. 562, 191-197. DOI |
24 | Nestler, E.J. (2001). Molecular basis of long-term plasticity underlying addiction. Nature reviews neuroscience. 2, 119. DOI |
25 | Nestler, E.J. (2004). Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25, 210-218. DOI |
26 | Ohnishi, H., Murata, Y., Okazawa, H., and Matozaki, T. (2011). Src family kinases: modulators of neurotransmitter receptor function and behavior. Trends Neurosci. 34, 629-637. DOI |
27 | Dias, R.B., Ribeiro J.A., and Sebastiao A.M. (2012). Enhancement of AMPA currents and GluR1 membrane expression through PKAcoupled adenosine A(2A) receptors. Hippocampus 22, 276-291. DOI |
28 | Copeland, R. L., Jr., Pradhan, S.N., Dillon-Carter, O., Chuang, D.M. (1989). Rebound increase of basal cAMP level in NG108-15 cells during chronic morphine treatment: effects of naloxone and chloramphenicol. Life Sci. 44, 1107-1116. DOI |
29 | Das, S., M. Grunert, L. Williams and S. R. Vincent (1997). NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c‐fos in striatal neurons in primary culture. Synapse 25, 227-233. DOI |
30 | Derkach, V., Barria, A., and Soderling, T.R. (1999). Ca2+/calmodulinkinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc. Natl. Acad. Sci. USA 96, 3269-3274. DOI |
31 | Ding, J., Guzman, J.N., Tkatch, T., Chen, S., Goldberg, J.A., Ebert, P.J., Levitt, P., Wilson, C.J., Hamm, H.E., and Surmeier, D.J. (2006). RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat. Neurosci. 9, 832-842. DOI |
32 | Robbe, D., Bockaert, J., and Manzoni, O.J. (2002). Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice. Eur. J. Neurosci. 16, 2231-2235. DOI |
33 | Dobi, A., Seabold, G.K. Christensen, C.H. Bock R., and Alvarez, V.A. (2011). Cocaine-induced plasticity in the nucleus accumbens is cell specific and develops without prolonged withdrawal. J. Neurosci. 31, 1895-1904. DOI |
34 | Garcia-Perez, D., Nunez, C., Laorden M.L., and Milanes, M.V. (2016). Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal. Addict. Biol. 21, 374-386. DOI |
35 | Parsegian, A., and See, R.E. (2014). Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats. Neuropsychopharmacology 39, 811-822. DOI |
36 | Popik, P., and Kolasiewicz, W. (1999). Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn Schmiedebergs Arch. Pharmacol. 359, 288-294. |
37 | Popik, P., and Wrobel, M. (2002). Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43, 1210-1217. DOI |
38 | Schwendt, M. and McGinty, J.F. (2007). Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization. J. Pharmacol. Exp. Ther. 323, 650-657. DOI |
39 | Schwendt, M., Gold, S.J. and McGinty, J.F. (2006). Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. J. Neurochem. 96, 1606-1615. DOI |
40 | Schwendt, M., Hearing, M.C., See, R.E., and McGinty, J.F. (2007). Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum. Neuroreport 18, 1261-1265. DOI |
41 | Schwendt, M., Sigmon, S.A., and McGinty, J.F. (2012). RGS4 overexpression in the rat dorsal striatum modulates mGluR5- and amphetamine-mediated behavior and signaling. Psychopharmacology 221, 621-635. DOI |
42 | Grillet, N., Pattyn, A., Contet, C., Kieffer, B.L., Goridis C., and Brunet, J.F. (2005). Generation and characterization of Rgs4 mutant mice. Mol. Cell Biol. 25, 4221-4228. DOI |
43 | Gaspari, S., Papachatzaki, M.M., Koo, J.W., Carr, F.B., Tsimpanouli, M.E., Stergiou, E., Bagot, R.C., Ferguson, D., Mouzon, E., Chakravarty, S., Deisseroth, K., Lobo, M.K., and Zachariou V. (2014). Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine. Neuropsychopharmacology 39, 1968-1977. DOI |
44 | Goeders, N.E., Lane, J.D., and Smith, J.E. (1984). Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20, 451-455. DOI |
45 | Gonzalez, P., Cabello, P., Germany, A., Norris, B., and Contreras, E. (1997). Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur. J. Pharmacol. 332, 257-262. DOI |
46 | Han, M.H., Renthal, W., Ring, R.H., Rahman, Z., Psifogeorgou, K., Howland, D., Birnbaum, S., Young, K., Neve, R., Nestler, E.J., et al. (2010). Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol. Psychiatry 67, 761-769. DOI |
47 | Inoue, M., Mishina, M., and Ueda, H. (2003). Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23, 6529-6536. DOI |
48 | Bilodeau, J., and Schwendt, M. (2016). Post‐cocaine changes in regulator of G‐protein signaling (RGS) proteins in the dorsal striatum: Relevance for cocaine‐seeking and protein kinase C‐mediated phosphorylation. Synapse 70, 432-440. DOI |
49 | Ai, W., Gong J., and Yu, L. (1999). MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3‐kinase but not the cAMP/PKA pathway. FEBS Lett. 456, 196-200. DOI |